Over the past 12 months, 1 insider at Phathom Pharmaceuticals, Inc. filed 2 open-market SEC Form 4 transactions on PHAT: 0 purchases worth $0 and 2 sales worth $13K. Insiders have been net sellers over this period. The most recent filing was on Nov 3, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 25 | Robert Charles BreedlovePrincipal Accounting Officer | SELL | 524 | $13.51 | $7K |
| Sep 5, 25 | Robert Charles BreedlovePrincipal Accounting Officer | SELL | 461 | $12.09 | $6K |
| Jul 16, 25 | Robert Charles BreedlovePrincipal Accounting Officer | SELL | 1.7K | $8.36 | $14K |
| May 21, 25 | James N TopperDirector | BUY | 3.8K | $3.86 | $15K |
| May 14, 25 | James N TopperDirector | BUY | 6.3K | $3.32 | $21K |
| May 13, 25 | James N TopperDirector | BUY | 1.1K | $3.16 | $4K |
| May 12, 25 | James N TopperDirector | BUY | 12.6K | $3.04 | $38K |
| May 9, 25 | James N TopperDirector | BUY | 33.4K | $3.62 | $106K |
| May 7, 25 | Asit ParikhDirector | BUY | 5.0K | $2.40 | $12K |
| May 6, 25 | Asit ParikhDirector | BUY | 5.0K | $2.60 | $13K |
| Apr 7, 25 | Molly HendersonCFO and CBO | SELL | 3.7K | $4.55 | $17K |
| Mar 13, 25 | Asit ParikhDirector | BUY | 10.0K | $4.42 | $44K |
| Jan 21, 25 | Terrie CurranPresident and Chief Executive | SELL | 19.1K | $6.59 | $126K |
| Jan 21, 25 | Molly HendersonCFO and CBO | SELL | 6.6K | $6.59 | $43K |
| Jan 21, 25 | Azmi NabulsiChief Operating Officer | SELL | 7.9K | $6.59 | $52K |
| Dec 19, 24 | Molly HendersonCFO and CBO | SELL | 1.3K | $8.00 | $10K |
| Dec 19, 24 | Azmi NabulsiChief Operating Officer | SELL | 1.1K | $8.00 | $9K |
| Dec 13, 24 | Frank KarbeDirector | BUY | 12.5K | $7.93 | $99K |
| Dec 13, 24 | Asit ParikhDirector | BUY | 10.0K | $8.12 | $81K |
| Jul 15, 24 | Terrie CurranPresident and Chief Executive | SELL | 33.8K | $11.72 | $397K |
| Jul 15, 24 | Molly HendersonCFO and CBO | SELL | 4.3K | $11.72 | $51K |
| Jul 15, 24 | Azmi NabulsiChief Operating Officer | SELL | 10.9K | $11.72 | $128K |
| Apr 8, 24 | Molly HendersonCFO and CBO | SELL | 3.4K | $11.10 | $38K |
| Mar 22, 24 | Terrie CurranPresident and Chief Executive | SELL | 16.9K | $9.11 | $154K |
| Jan 24, 24 | Takeda Pharmaceutical Co LtdTenPercentOwner | SELL | 3.70M | $8.10 | $30.0M |
| Jan 19, 24 | Molly HendersonCFO and CBO | SELL | 6.3K | $7.75 | $49K |
| Nov 20, 23 | Molly HendersonCFO and CBO | SELL | 2.1K | $7.24 | $15K |
| Nov 8, 23 | Asit ParikhDirector | BUY | 2.5K | $7.80 | $20K |
| Nov 7, 23 | Asit ParikhDirector | BUY | 4.0K | $7.76 | $31K |
| Nov 6, 23 | Asit ParikhDirector | BUY | 1.0K | $8.04 | $8K |
| Nov 1, 23 | Molly HendersonCFO and CBO | SELL | 11.7K | $8.95 | $105K |
| Jun 2, 23 | Molly HendersonCFO and CBO | SELL | 2.0K | $11.41 | $22K |
| May 22, 23 | Molly HendersonCFO and CBO | SELL | 2.1K | $12.87 | $27K |
| Apr 11, 23 | Azmi NabulsiChief Operating Officer | BUY | 10.0K | $8.26 | $83K |
| Apr 10, 23 | Asit ParikhDirector | BUY | 1.0K | $7.55 | $8K |
| Apr 6, 23 | Terrie CurranPresident and Chief Executive | BUY | 12.9K | $7.82 | $101K |
| Apr 6, 23 | Molly HendersonCFO and CBO | SELL | 3.4K | $7.27 | $25K |
| Mar 1, 23 | Terrie CurranPresident and Chief Executive | SELL | 1.4K | $8.54 | $12K |
| Mar 1, 23 | Molly HendersonCFO and CBO | SELL | 2.0K | $8.53 | $17K |
| Feb 13, 23 | Asit ParikhDirector | BUY | 5.0K | $7.73 | $39K |
| Jan 20, 23 | Terrie CurranPresident and Chief Executive | SELL | 5.8K | $8.20 | $48K |
| Jan 12, 23 | Asit ParikhDirector | BUY | 5.0K | $7.00 | $35K |
| Nov 21, 22 | Terrie CurranPresident and Chief Executive | SELL | 1.5K | $9.60 | $15K |
| Nov 21, 22 | Molly HendersonCFO and CBO | SELL | 2.2K | $9.60 | $21K |
| May 16, 22 | Azmi NabulsiChief Operating Officer | BUY | 20.0K | $8.16 | $163K |
| May 13, 22 | Terrie CurranPresident and Chief Executive | BUY | 20.5K | $7.41 | $152K |
| May 13, 22 | Molly HendersonCFO and CBO | BUY | 6.0K | - | $0 |
| May 12, 22 | Asit ParikhDirector | BUY | 12.5K | $8.00 | $100K |
| Mar 14, 22 | Takeda Pharmaceutical Co LtdTenPercentOwner | SELL | 18 | $19.00 | $342 |
| Nov 4, 21 | Takeda Pharmaceutical Co LtdTenPercentOwner | SELL | 1.00M | $20.85 | $20.9M |
Over the past 12 months, insiders at Phathom Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 2 sales worth $13K on PHAT, which makes them net sellers over the period. The most recent Form 4 was filed on Nov 3, 25.
The largest recent open-market PHAT insider purchase in our data was $163K by Azmi Nabulsi, Chief Operating Officer, filed on May 16, 22.
1 different insider at Phathom Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on PHAT over the last 12 months.
InsiderTape plots every PHAT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Phathom Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →